Similar articles

• Parenteral ciprofloxacin compared with ceftazidime in the treatment of serious upper and lower urinary tract infection.

  Palmer DL, Koster FT. Palmer DL, et al. Diagn Microbiol Infect Dis. 1990 Mar-Apr;13(2):157-60. doi: 10.1016/0732-8893(90)90100-a. Diagn Microbiol Infect Dis. 1990. PMID: 2196151 Clinical Trial. No abstract available.
• Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections.

  Cox CE. Cox CE. Am J Med. 1989 Nov 30;87(5A):157S-159S. doi: 10.1016/0002-9343(89)90048-x. Am J Med. 1989. PMID: 2686415 No abstract available.
• Prospective, controlled, randomized, non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of severe surgical infections.

  Del Rosal PL, Del Rosal LL, Riosvelasco CA, Nesbitt FC, Alanis VS. Del Rosal PL, et al. Am J Med. 1989 Nov 30;87(5A):183S-184S. doi: 10.1016/0002-9343(89)90054-5. Am J Med. 1989. PMID: 2686420 Clinical Trial. No abstract available.
• [New prospects in the treatment of urinary tract infections with modified-release ciprofloxacin].

  Trinchieri A. Trinchieri A. Arch Ital Urol Androl. 2006 Sep;78(3 Suppl 1):1-8. Arch Ital Urol Androl. 2006. PMID: 17469403 Review. Italian. No abstract available.
• [A review of clinical studies on the efficacy and tolerance of intravenous ciprofloxacin].

  Memoli M. Memoli M. Recenti Prog Med. 1992 Jan;83(1):27-34. Recenti Prog Med. 1992. PMID: 1561480 Review. Italian.